|
PVRIG Expression Is an Independent Prognostic Factor and a New Potential Target for Immunotherapy in Hepatocellular Carcinoma
David Jeremie Birnbaum
,
Maelle Picard
,
Quentin da Costa
,
Thomas Delayre
,
Pascal Finetti
et al.
Journal articles
hal-03958279v1
|
|
Timing evolution of lobular breast cancer through phylogenetic analysis
Danai Fimereli
,
David Venet
,
Mattia Rediti
,
Bram Boeckx
,
Marion Maetens
et al.
Journal articles
hal-04084988v1
|
|
First-in-Human, Phase I Study of PCA062 in Solid Tumors—Letter
Bernadette de Rauglaudre
,
Pascal Finetti
,
David Jérémie Birnbaum
,
Marc Lopez
,
François Bertucci
et al.
Journal articles
hal-03958336v1
|
|
Immune-Desert Tumor Microenvironment in Thoracic SMARCA4-Deficient Undifferentiated Tumors with Limited Efficacy of Immune Checkpoint Inhibitors
Justine Gantzer
,
Guillaume Davidson
,
Bujamin Vokshi
,
Noëlle Weingertner
,
Antoine Bougoüin
et al.
Journal articles
hal-03623495v1
|
|
Patterns of care and outcomes of 417 patients with METAstatic SYNovial sarcoma (METASYN): real-life data from the French Sarcoma Group (FSG)
C. Moreau-Bachelard
,
L. Campion
,
M. Toulmonde
,
A. Le Cesne
,
M. Brahmi
et al.
Journal articles
hal-03623511v1
|
|
Menin inhibition suppresses castration-resistant prostate cancer and enhances chemosensitivity
Chaïma Cherif
,
Dang Tan Nguyen
,
Clément Paris
,
Thi Khanh Le
,
Thibaud Sefiane
et al.
Journal articles
hal-03599176v1
|
|
Pathological complete response rate and disease-free survival after neoadjuvant chemotherapy in patients with HER2-low and HER2-0 breast cancers
Alexandre De Nonneville
,
Gilles Houvenaeghel
,
Monique Cohen
,
Laura Sabiani
,
Marie Bannier
et al.
Journal articles
hal-04084964v1
|
|
Circulating tumor DNA predicts efficacy of a dual AKT/p70S6K inhibitor (LY2780301) plus paclitaxel in metastatic breast cancer: plasma analysis of the TAKTIC phase IB/II study
Renaud Sabatier
,
Cécile Vicier
,
Séverine Garnier
,
Arnaud Guille
,
Nadine Carbuccia
et al.
Journal articles
hal-03583253v1
|
|
A 10-miRNA risk score-based prediction model for pathological complete response to neoadjuvant chemotherapy in hormone receptor-positive breast cancer
Chang Gong
,
Ziliang Cheng
,
Yaping Yang
,
Jun Shen
,
Yingying Zhu
et al.
Journal articles
hal-04085305v1
|
|
No Geographical Inequalities in Survival for Sarcoma Patients in France: A Reference Networks' Outcome?
Yohan Fayet
,
Christine Chevreau
,
Gauthier Decanter
,
Cécile Dalban
,
Pierre Méeus
et al.
Journal articles
hal-03718397v1
|
|
Investigation of Molecular Features Involved in Clinical Responses and Survival in Advanced Endometrial Carcinoma Treated by Hormone Therapy
Mathias Neron
,
Arnaud Guille
,
Lucie Allègre
,
Pierre-Emmanuel Colombo
,
Cristina Marinella Leaha
et al.
Journal articles
hal-03765663v1
|
|
CSPG4 Expression in GIST Is Associated with Better Prognosis and Strong Cytotoxic Immune Response
Alexandre De Nonneville
,
Pascal Finetti
,
Maelle Picard
,
Audrey Monneur
,
Maria Abbondanza Pantaleo
et al.
Journal articles
hal-04085332v1
|
|
CISH Expression Is Associated with Metastasis-Free Interval in Triple-Negative Breast Cancer and Refines the Prognostic Value of PDL1 Expression
Laurys Boudin
,
Alexandre de Nonneville
,
Pascal Finetti
,
Geoffrey Guittard
,
Jacques Nunes
et al.
Journal articles
hal-03765362v1
|
|
Immunologic constant of rejection signature is prognostic in soft-tissue sarcoma and refines the CINSARC signature
Francois Bertucci
,
Vincent Niziers
,
Alexandre de Nonneville
,
Pascal Finetti
,
Léna Mescam
et al.
Journal articles
hal-03583256v1
|
|
Comprehensive metabolomics expands precision medicine for triple-negative breast cancer
Yi Xiao
,
Ding Ma
,
Yun-Song Yang
,
Fan Yang
,
Jia-Han Ding
et al.
Journal articles
hal-03623509v1
|
|
Rare bone sarcomas: A retrospective analysis of 145 adult patients from the French Sarcoma Group
Pascaline Boudou‐rouquette
,
Elodie Martin
,
Emmanuelle Kempf
,
Nicolas Penel
,
Maud Toulmonde
et al.
Journal articles
hal-03560233v1
|
|
CSPG4 expression in soft tissue sarcomas is associated with poor prognosis and low cytotoxic immune response
Laurys Boudin
,
A de Nonneville
,
Pascal Finetti
,
Léna Mescam
,
A Le Cesne
et al.
Journal articles
hal-03958345v1
|
|
EGFR is a master switch between immunosuppressive and immunoactive tumor microenvironment in inflammatory breast cancer
Xiaoping Wang
,
Takashi Semba
,
Ganiraju C. Manyam
,
Jing Wang
,
Shan Shao
et al.
Journal articles
hal-04084958v1
|
|
Molecular Profiles of Advanced Urological Cancers in the PERMED-01 Precision Medicine Clinical Trial
Émilien Billon
,
Gwenaelle Gravis
,
Arnaud Guille
,
Nadine Carbuccia
,
José Adélaïde
et al.
Journal articles
hal-04085310v1
|
|
Repeated Multimodality Ablative Therapies for Oligorecurrent Pulmonary Metastatic Disease
Alban Macagno
,
Alexandre De Nonneville
,
Pierre Annede
,
Gilles Piana
,
Isabelle Pougnet
et al.
Journal articles
hal-04085333v1
|
|
MARCKS as a Potential Therapeutic Target in Inflammatory Breast Cancer
Maroua Manai
,
Ines Elbini-Dhouib
,
Pascal Finetti
,
Haifa Bichiou
,
Carolina Reduzzi
et al.
Journal articles
hal-03958360v1
|
|
Identification of Atypical Circulating Tumor Cells with Prognostic Value in Metastatic Breast Cancer Patients
Alexia Lopresti
,
Claire Acquaviva
,
Laurys Boudin
,
Pascal Finetti
,
Séverine Garnier
et al.
Journal articles
hal-03583233v1
|
|
RE: NDRG1 in Aggressive Breast Cancer Progression and Brain Metastasis
Alexandre de Nonneville
,
Pascal Finetti
,
Emilie Mamessier
,
François Bertucci
Journal articles
hal-03583244v1
|
|
Comparative transcriptional analyses of preclinical models and patient samples reveal MYC and RELA driven expression patterns that define the molecular landscape of IBC
Charlotte Rypens
,
F. Bertucci
,
Pascal Finetti
,
Fredika Robertson
,
Sandra Fernandez
et al.
Journal articles
hal-03623626v1
|
|
Identification of Atypical Circulating Tumor Cells with Prognostic Value in Metastatic Breast Cancer Patients
Alexia Lopresti
,
Claire Acquaviva
,
Laurys Boudin
,
Pascal Finetti
,
Séverine Garnier
et al.
Journal articles
hal-03637735v1
|
|
Évolution et facteurs associés à la publication des travaux de thèse d’exercice par les internes d’oncologie médicale en France
Alexandre de Nonneville
,
F. Bertucci
,
Éric Lambaudie
,
Gilles Houvenaeghel
,
Renaud Sabatier
et al.
Journal articles
hal-03623519v1
|
|
Ketogenic HMG‐CoA lyase and its product β‐hydroxybutyrate promote pancreatic cancer progression
Victoire Gouirand
,
Tristan Gicquel
,
Evan Lien
,
Emilie Jaune‐pons
,
Quentin da Costa
et al.
Journal articles
hal-03623502v1
|
|
BMI1 nuclear location is critical for RAD51-dependent response to replication stress and drives chemoresistance in breast cancer stem cells
Violette Azzoni
,
Julien Wicinski
,
Manon Macario
,
Martin Castagné
,
Pascal Finetti
et al.
Journal articles
hal-03623505v1
|
|
TOP3A amplification and ATRX inactivation are mutually exclusive events in pediatric osteosarcomas using ALT
Alexandre de Nonneville
,
Sébastien Salas
,
François Bertucci
,
Alexander P Sobinoff
,
José Adélaïde
et al.
Journal articles
hal-03877721v1
|
|
Loss of primary cilia promotes inflammation and carcinogenesis
Conception Paul
,
Ruizhi Tang
,
Ciro Longobardi
,
Rossano Lattanzio
,
Thibaut Eguether
et al.
Journal articles
hal-03856745v1
|
|
TAKTIC: A prospective, multicentre, uncontrolled, phase IB/II study of LY2780301, a p70S6K/AKT inhibitor, in combination with weekly paclitaxel in HER2-negative advanced breast cancer patients
Cecile Vicier
,
Patrick Sfumato
,
Nicolas Isambert
,
Florence Dalenc
,
Marie Robert
et al.
Journal articles
hal-03622797v1
|
|
Expression of X-Linked Inhibitor of Apoptosis Protein (XIAP) in Breast Cancer Is Associated with Shorter Survival and Resistance to Chemotherapy
Gayathri Devi
,
Pascal Finetti
,
Michael Morse
,
Seayoung Lee
,
Alexandre de Nonneville
et al.
Journal articles
hal-03623076v1
|
|
Alpelisib and fulvestrant efficacy in HR-positive HER2-negative PIK3CA -mutant advanced breast cancer: Data from the French early access program.
F. Bertucci
,
Diana Bello
,
Alexandre Bertucci
,
Thibault de La Motte Rouge
,
Cyriac Blonz
et al.
Journal articles
hal-03623116v1
|
|
EFA6B regulates a stop signal for collective invasion in breast cancer
Racha Fayad
,
Monserrat Vázquez Rojas
,
Mariagrazia Partisani
,
Pascal Finetti
,
Shiraz Dib
et al.
Journal articles
hal-03434635v1
|
|
Case report: Two cases of metastatic pancreatoblastoma in adults: efficacy of Folfirinox and implication of the wnt/β-catenin pathway in genomic analysis
Jean-Luc Raoul
,
Sandrine Oziel-Taieb
,
Thierry Lecomte
,
José Adelaide
,
Arnaud Guille
et al.
Journal articles
hal-03623119v1
|
|
Prospective high-throughput genome profiling of advanced cancers: results of the PERMED-01 clinical trial
François Bertucci
,
Anthony Gonçalves
,
Arnaud Guille
,
José Adelaïde
,
Séverine Garnier
et al.
Journal articles
hal-03583277v1
|
|
Determinants of the access to remote specialised services provided by national sarcoma reference centres
Yohan Fayet
,
Raphaël Tétreau
,
Charles Honoré
,
Louis-Romée Le Nail
,
Cécile Dalban
et al.
Journal articles
inserm-03243378v1
|
|
Lipocalin 2 promotes inflammatory breast cancer tumorigenesis and skin invasion
Emilly Villodre
,
Xiaoding Hu
,
Richard Larson
,
Pascal Finetti
,
Kristen Gomez
et al.
Journal articles
hal-03623121v1
|
|
Transcriptomic Analysis of Laser Capture Microdissected Tumors Reveals Cancer- and Stromal-Specific Molecular Subtypes of Pancreatic Ductal Adenocarcinoma
David Birnbaum
,
Sebastian K.S. Begg
,
Pascal Finetti
,
Charles Vanderburg
,
Anupriya Kulkarni
et al.
Journal articles
hal-03623108v1
|
|
A single-arm multicentre phase II trial of doxorubicin in combination with trabectedin in the first-line treatment for leiomyosarcoma with long-term follow-up and impact of cytoreductive surgery
P. Pautier
,
A. Floquet
,
C. Chevreau
,
N. Penel
,
C. Guillemet
et al.
Journal articles
hal-03623631v1
|
|
Anthracycline-free or short-term regimen as adjuvant chemotherapy for operable breast cancer: A phase III randomized non-inferiority trial
Ke-Da Yu
,
Xi-Yu Liu
,
Li Chen
,
Miao Mo
,
Jiong Wu
et al.
Journal articles
hal-03623636v1
|
|
LDL receptor-peptide conjugate as in vivo tool for specific targeting of pancreatic ductal adenocarcinoma.
Angélina Acier
,
Magali Godard
,
Fanny Gassiot
,
Pascal Finetti
,
Marion Rubis
et al.
Journal articles
hal-03452855v1
|
|
Immune landscape of inflammatory breast cancer suggests vulnerability to immune checkpoint inhibitors
François Bertucci
,
Laurys Boudin
,
Pascal Finetti
,
Christophe van Berckelaer
,
Peter van Dam
et al.
Journal articles
hal-03583271v1
|
|
CD44v6 Defines a New Population of Circulating Tumor Cells Not Expressing EpCAM
Guillaume Belthier
,
Zeinab Homayed
,
Fanny Grillet
,
Christophe Duperray
,
Julie Vendrell
et al.
Journal articles
hal-03394453v1
|
|
Circulating tumor DNA as a noninvasive marker of resectability in ovarian carcinomas.
Roxane Mari
,
Christophe Pomel
,
Pierre-Emmanuel Colombo
,
Fabrice Narducci
,
Séverine Garnier
et al.
Journal articles
hal-03622754v1
|
|
The Evolution and Prognostic Role of Tumour-Infiltrating Lymphocytes and Peripheral Blood-Based Biomarkers in Inflammatory Breast Cancer Patients Treated with Neoadjuvant Chemotherapy
Christophe van Berckelaer
,
Iris Vermeiren
,
Leonie Vercauteren
,
Charlotte Rypens
,
Gizem Oner
et al.
Journal articles
hal-03623094v1
|
|
CRYODESMO-O1: A prospective, open phase II study of cryoablation in desmoid tumour patients progressing after medical treatment
Jean-Emmanuel Kurtz
,
Xavier Buy
,
Frédéric Deschamps
,
Erik Sauleau
,
Amine Bouhamama
et al.
Journal articles
hal-03623642v1
|
|
Efficacy and safety of regorafenib in patients with metastatic or locally advanced chondrosarcoma: Results of a non-comparative, randomised, double-blind, placebo controlled, multicentre phase II study
Florence Duffaud
,
Antoine Italiano
,
Emannuelle Bompas
,
Maria Rios
,
Nicolas Penel
et al.
Journal articles
hal-03623638v1
|
|
The CINSARC signature predicts the clinical outcome in patients with Luminal B breast cancer
Anthony Goncalves
,
Pascal Finetti
,
Daniel Birnbaum
,
F. Bertucci
Journal articles
hal-03623055v1
|
|
Cyclin A2 maintains colon homeostasis and is a prognostic factor in colorectal cancer
Yuchen Guo
,
Monica Gabola
,
Rossano Lattanzio
,
Conception Paul
,
Valérie Pinet
et al.
Journal articles
hal-03152320v1
|
|
739P Efficacy and safety of maintenance olaparib and bevacizumab (bev) in ovarian cancer (OC) patients (pts) aged ≥65 years (y) from the PAOLA-1/ENGOT-ov25 first-line trial
Renaud Sabatier
,
Cécile Vicier
,
Séverine Garnier
,
Arnaud Guille
,
Nadine Carbuccia
et al.
Journal articles
hal-03622737v1
|
|
Quantification of Immune Variables from Liquid Biopsy in Breast Cancer Patients Links Vδ2+ γδ T Cell Alterations with Lymph Node Invasion
Stéphane Fattori
,
Laurent Gorvel
,
Samuel Granjeaud
,
Philippe Rochigneux
,
Marie-Sarah Rouvière
et al.
Journal articles
hal-03152759v1
|
|
Case Report: Grade 2 Metastatic Pancreatic Neuroendocrine Tumor With Progression of One Metastasis After Pregnancy to Grade 3 Large-Cell Neuroendocrine Carcinoma: One Case Cured by Resection With Genomic Characterization of the Two Components
Jean-Luc Raoul
,
Marie-Françoise Heymann
,
Frédéric Dumont
,
Alain Morel
,
Hélène Senellart
et al.
Journal articles
hal-03623095v1
|
|
Antisense Oligonucleotide-Based Therapeutic against Menin for Triple-Negative Breast Cancer Treatment
Dang Tan Nguyen
,
Thi Khanh Le
,
Clément Paris
,
Chaïma Cherif
,
Stéphane Audebert
et al.
Journal articles
hal-03599175v1
|
|
Metabolic-Pathway-Based Subtyping of Triple-Negative Breast Cancer Reveals Potential Therapeutic Targets
Yue Gong
,
Peng Ji
,
Yun-Song Yang
,
Shao Xie
,
Tian-Jian Yu
et al.
Journal articles
hal-03623115v1
|
|
WEE1 Dependency and Pejorative Prognostic Value in Triple‐Negative Breast Cancer
Alexandre Nonneville
,
Pascal Finetti
,
Daniel Birnbaum
,
Emilie Mamessier
,
François Bertucci
et al.
Journal articles
hal-03583269v1
|
|
Metastatic inflammatory breast cancer: survival outcomes and prognostic factors in the national, multicentric, and real-life French cohort (ESME)
D. Dano
,
A. Lardy-Cleaud
,
A. Monneur
,
N. Quenel-Tueux
,
C. Levy
et al.
Journal articles
hal-03426433v1
|
|
Starting Imatinib at 400 mg Daily in Patients with Gastrointestinal Stromal Tumors Harboring KIT Exon 9 Mutations: A Retrospective, Multicenter Study
Almudena Callejo
,
Sara Faouzi
,
Olivier Bouché
,
F. Bertucci
,
Thomas Chevalier
et al.
Journal articles
hal-03623633v1
|
|
A Multicenter Phase II Study of Pazopanib in Patients with Unresectable Dermatofibrosarcoma Protuberans
Julie Delyon
,
Raphael Porcher
,
Maxime Battistella
,
Nicolas Meyer
,
Henri Adamski
et al.
Journal articles
hal-03623658v1
|
|
Characterization of Stromal Tumor-infiltrating Lymphocytes and Genomic Alterations in Metastatic Lobular Breast Cancer
François Richard
,
Samira Majjaj
,
David Venet
,
Françoise Rothé
,
Julien Pingitore
et al.
Journal articles
hal-03623659v1
|
|
Pharmacogenetic Study of Trabectedin-Induced Severe Hepatotoxicity in Patients with Advanced Soft Tissue Sarcoma
Maud Maillard
,
Christine Chevreau
,
Félicien Le Louedec
,
Manon Cassou
,
Caroline Delmas
et al.
Journal articles
hal-03623645v1
|
|
A phase II of gemcitabine combined with pazopanib followed by pazopanib maintenance, as second-line treatment in patients with advanced leiomyosarcomas: A unicancer French Sarcoma Group study (LMS03 study)
P. Pautier
,
N. Penel
,
I. Ray-Coquard
,
A. Italiano
,
E. Bompas
et al.
Journal articles
hal-02429038v1
|
|
Santé numérique et « cancer hors les murs », Big Data et intelligence artificielle
Francois Bertucci
,
Anne-Gaëlle Le Corroller-Soriano
,
Audrey Monneur
,
Sylvain Fluzin
,
Patrice Viens
et al.
Journal articles
hal-02505031v1
|
|
Cancer-testis Antigen FATE1 Expression in Adrenocortical Tumors Is Associated with A Pervasive Autoimmune Response and Is A Marker of Malignancy in Adult, but Not Children, ACC
Mabrouka Doghman-Bouguerra
,
Pascal Finetti
,
Nelly Durand
,
Ivy Zortéa S Parise
,
Silviu Sbiera
et al.
Journal articles
inserm-02508381v1
|
|
New Therapeutics in HER2-Positive Advanced Breast Cancer: Towards a Change in Clinical Practices?
Essia Mezni
,
Cécile Vicier
,
Mathilde Guerin
,
Renaud Sabatier
,
François Bertucci
et al.
Journal articles
hal-03623669v1
|
|
Revisiting the Concept of Stress in the Prognosis of Solid Tumors: A Role for Stress Granules Proteins?
Anaïs Aulas
,
Pascal Finetti
,
Shawn Lyons
,
François Bertucci
,
Daniel Birnbaum
et al.
Journal articles
hal-03606494v1
|
|
A double-blind placebo-controlled randomized phase II trial assessing the activity and safety of regorafenib in non-adipocytic sarcoma patients previously treated with both chemotherapy and pazopanib
Nicolas Penel
,
Olivier Mir
,
Jennifer Wallet
,
Isabelle Ray-Coquard
,
Axel Le Cesne
et al.
Journal articles
hal-03623680v1
|
|
Quantitative hormone receptor (HR) expression and gene expression analysis in HR+ inflammatory breast cancer (IBC) vs non-IBC
Toshiaki Iwase
,
Kenichi Harano
,
Hiroko Masuda
,
Kumiko Kida
,
Kenneth R Hess
et al.
Journal articles
inserm-02913696v1
|
|
Theranostic Targeting of CUB Domain Containing Protein 1 (CDCP1) in Pancreatic Cancer—Letter
David Birnbaum
,
Pascal Finetti
,
Daniel Birnbaum
,
F. Bertucci
Journal articles
hal-03623653v1
|
|
Inflammatory breast cancer cells are characterized by abrogated TGFβ1-dependent cell motility and SMAD3 activity
Charlotte Rypens
,
Melike Marsan
,
Christophe van Berckelaer
,
Charlotte Billiet
,
Kirsten Melis
et al.
Journal articles
hal-03623677v1
|
|
Novel Therapeutic Insights in Dedifferentiated Liposarcoma: A Role for FGFR and MDM2 Dual Targeting
Bérengère Dadone-Montaudié
,
Audrey Laroche-Clary
,
Aline Mongis
,
Emmanuel Chamorey
,
Ilaria Di Mauro
et al.
Journal articles
hal-03034592v1
|
|
Neoplastic–Stromal Cell Cross-talk Regulates Matrisome Expression in Pancreatic Cancer
Kim Honselmann
,
Pascal Finetti
,
David Birnbaum
,
Christian Monsalve
,
Ulrich Wellner
et al.
Journal articles
hal-03623660v1
|
|
The therapeutic response of ER+/HER2− breast cancers differs according to the molecular Basal or Luminal subtype
François Bertucci
,
Pascal Finetti
,
Anthony Goncalves
,
Daniel Birnbaum
Journal articles
hal-03623676v1
|
|
PELICAN-IPC 2015-016/Oncodistinct-003: A Prospective, Multicenter, Open-Label, Randomized, Non-Comparative, Phase II Study of Pembrolizumab in Combination With Neo Adjuvant EC-Paclitaxel Regimen in HER2-Negative Inflammatory Breast Cancer
Alexandre Bertucci
,
F. Bertucci
,
Christophe Zemmour
,
Florence Lerebours
,
Jean-Yves Pierga
et al.
Journal articles
hal-03623650v1
|
|
Revisiting the Concept of Stress in the Prognosis of Solid Tumors: A Role for Stress Granules Proteins?
Anaïs Aulas
,
Pascal Finetti
,
Shawn M Lyons
,
François Bertucci
,
Daniel Birnbaum
et al.
Journal articles
hal-02958029v1
|
|
Combining poly(ADP-ribose) polymerase inhibitors and immune checkpoint inhibitors in breast cancer: rationale and preliminary clinical results
Anthony Goncalves
,
Essia Mezni
,
F. Bertucci
Journal articles
hal-03623648v1
|
|
PARP Inhibitors in the Treatment of Early Breast Cancer: The Step Beyond?
Anthony Gonçalves
,
Alexandre Bertucci
,
François Bertucci
Journal articles
hal-03623672v1
|
|
ERBB2b mRNA isoform encodes a nuclear variant of the ERBB2 oncogene in breast cancer
Guoqiang Hua
,
Aurélie Bergon
,
Pierre Cauchy
,
Brigitte Kahn‐perlès
,
François Bertucci
et al.
Journal articles
hal-02897104v1
|
|
Surgical Margins and Adjuvant Therapies in Malignant Phyllodes Tumors of the Breast: A Multicenter Retrospective Study
Mathias Neron
,
Christophe Sajous
,
Simon Thezenas
,
Sophie Piperno-Neumann
,
Fabien Reyal
et al.
Journal articles
hal-03623684v1
|
|
Publisher Correction: SLX4 interacts with RTEL1 to prevent transcription-mediated DNA replication perturbations
A. Takedachi
,
E. Despras
,
S. Scaglione
,
R. Guérois
,
J. Guervilly
et al.
Journal articles
hal-02997075v1
|
|
High throughput profiling of undifferentiated pleomorphic sarcomas identifies two main subgroups with distinct immune profile, clinical outcome and sensitivity to targeted therapies
Maud Toulmonde
,
Carlo Lucchesi
,
Stéphanie Verbeke
,
Amandine Crombe
,
Julien Adam
et al.
Journal articles
hal-03034609v1
|
|
SLX4 interacts with RTEL1 to prevent transcription-mediated DNA replication perturbations
A. Takedachi
,
E. Despras
,
S. Scaglione
,
R. Guérois
,
J. Guervilly
et al.
Journal articles
hal-02995970v1
|
|
Genomic landscape of inflammatory breast cancer identifies potential actionable genetic alterations
François Bertucci
,
Steven Van Laere
,
Daniel Birnbaum
Journal articles
hal-03623667v1
|
|
NOTCH and DNA repair pathways are more frequently targeted by genomic alterations in inflammatory than in non‐inflammatory breast cancers
François Bertucci
,
Charlotte Rypens
,
Pascal Finetti
,
Arnaud Guille
,
José Adélaïde
et al.
Journal articles
hal-03623678v1
|
|
SLX4 interacts with RTEL1 to prevent transcription-mediated DNA replication perturbations.
A Takedachi
,
E Despras
,
S Scaglione
,
R Guérois
,
J Guervilly
et al.
Journal articles
hal-03023347v1
|
|
Enhancement of Breast Cancer Cell Aggressiveness by lncRNA H19 and its Mir-675 Derivative: Insight into Shared and Different Actions
Evodie Peperstraete
,
Clément Lecerf
,
Jordan Collette
,
Constance Vennin
,
Ludivine Raby
et al.
Journal articles
hal-02896573v1
|
|
SLX4 interacts with RTEL1 to prevent transcription-mediated DNA replication perturbations
A. Takedachi
,
E. Despras
,
S. Scaglione
,
R. Guérois
,
J. Guervilly
et al.
Journal articles
hal-03079782v1
|
|
Major Response to Carboplatin in a Patient With Metastatic Triple-Negative Breast Cancer With Somatic Mutation of BRCA1 and Loss of RAD51B
Lorène Seguin
,
Max Chaffanet
,
Séverine Garnier
,
José Adélaïde
,
Nadine Carbuccia
et al.
Journal articles
hal-03623688v1
|
|
Stem Cells Inhibition by Bevacizumab in Combination with Neoadjuvant Chemotherapy for Breast Cancer
Renaud Sabatier
,
Emmanuelle Charafe-Jauffret
,
Jean-Yves Pierga
,
Hervé Curé
,
Eric Lambaudie
et al.
Journal articles
hal-02145624v1
|
|
Validation of Neutrophil Count as An Algorithm-Based Predictive Factor of Progression-Free Survival in Patients with Metastatic Soft Tissue Sarcomas Treated with Trabectedin
Alexandre De Nonneville
,
Dominique Barbolosi
,
Maeva Andriantsoa
,
Raouf El-Cheikh
,
Florence Duffaud
et al.
Journal articles
hal-02461464v1
|
|
MARCKS protein overexpression is associated with poor prognosis in male breast cancer
Maroua Manai
,
Syrine Abdeljaoued
,
Aïda Goucha
,
Olfa Adouni
,
Ilhem Bettaieb
et al.
Journal articles
hal-02530358v1
|
|
Multi-Omics Profiling Reveals Distinct Microenvironment Characterization and Suggests Immune Escape Mechanisms of Triple-Negative Breast Cancer
Yi Xiao
,
Ding Ma
,
Shen Zhao
,
Chen Suo
,
Jinxiu Shi
et al.
Journal articles
hal-02533431v1
|
|
Surgery in reference centers improves survival of sarcoma patients: a nationwide study
J.-Y. Blay
,
C. Honore
,
E. Stoeckle
,
P. Méeus
,
M. Jafari
et al.
Annals of Oncology, 2019, Annals of oncology official journal of the European Society for Medical Oncology, 30 (7), pp.1143-1153. ⟨10.1093/annonc/mdz124⟩
Journal articles
hal-02509515v1
|
|
Outpatient Cancer Care Delivery in the Context of E-Oncology: A French Perspective on “Cancer outside the Hospital Walls”
François Bertucci
,
Anne-Gaëlle Le Corroller-Soriano
,
Audrey Monneur-Miramon
,
Jean-François Moulin
,
Sylvain Fluzin
et al.
Journal articles
inserm-02329449v1
|
|
Head and Body/Tail Pancreatic Carcinomas Are Not the Same Tumors
Shuichi Aoki
,
Koetsu Inoue
,
Sebastian Klein
,
Stefan Halvorsen
,
Jiang Chen
et al.
Journal articles
hal-03583447v1
|
|
Epigenetic down-regulation of the HIST1 locus predicts better prognosis in acute myeloid leukemia with NPM1 mutation
Sylvain Garciaz
,
Lia N’guyen Dasi
,
Pascal Finetti
,
Christine Chevalier
,
Julien Vernerey
et al.
Journal articles
hal-02322283v1
|
|
Oncogenic states dictate the prognostic and predictive connotations of intratumoral immune response
Jessica Roelands
,
Wouter Hendrickx
,
Gabriele Zoppoli
,
Raghvendra Mall
,
Mohamad Saad
et al.
Journal articles
hal-03623675v1
|
|
ECT2 associated to PRICKLE1 are poor-prognosis markers in triple-negative breast cancer
Luc Camoin
,
Jean-Paul Borg
,
Avais M Daulat
,
Pascal Finetti
,
Diego R Revinski
et al.
Journal articles
hal-02145896v1
|
|
Sarcomas in patients over 90: Natural history and treatment—A nationwide study over 6 years
Clémence Basse
,
Antoine Italiano
,
Nicolas Penel
,
Olivier Mir
,
Claire Chemin
et al.
Journal articles
hal-02504786v1
|
|
A Tyrosine Kinase Expression Signature Predicts the Post-Operative Clinical Outcome in Triple Negative Breast Cancers
Alexandre de Nonneville
,
Pascal Finetti
,
José Adelaïde
,
Eric Lambaudie
,
Patrice Viens
et al.
Journal articles
hal-02518929v1
|
|
XPO1 Expression Is a Poor-Prognosis Marker in Pancreatic Adenocarcinoma
David Jérémie Birnbaum
,
Pascal Finetti
,
Daniel Birnbaum
,
Emilie Mamessier
,
Francois Bertucci
et al.
Journal articles
hal-02509509v1
|
|
ECT2 associated to PRICKLE1 are poor-prognosis markers in triple-negative breast cancer
Avais M Daulat
,
Pascal Finetti
,
Diego R Revinski
,
Mônica Silveira Wagner
,
Luc Camoin
et al.
Journal articles
hal-02518543v1
|
|
A Comparison of DNA Mutation and Copy Number Profiles of Primary Breast Cancers and Paired Brain Metastases for Identifying Clinically Relevant Genetic Alterations in Brain Metastases
Marguerite Tyran
,
Nadine Carbuccia
,
Séverine Garnier
,
Arnaud Guille
,
José Adelaïde
et al.
Journal articles
hal-02533361v1
|
|
High Response to Cetuximab in a Patient With EGFR -Amplified Heavily Pretreated Metastatic Triple-Negative Breast Cancer
Renaud Sabatier
,
Marc Lopez
,
Arnaud Guille
,
Emilien Billon
,
Nadine Carbuccia
et al.
Journal articles
hal-03623686v1
|
|
Infiltrating stromal immune cells in inflammatory breast cancer are associated with an improved outcome and increased PD-L1 expression
C. van Berckelaer
,
C. Rypens
,
P. van Dam
,
L. Pouillon
,
M. Parizel
et al.
Journal articles
hal-02533387v1
|
|
Common origin of sequential cutaneous CD30+ lymphoproliferations with nodal involvement evidenced by genome-wide clonal evolution
Luc Xerri
,
José Adelaïde
,
Morgan Avenin
,
Arnaud Guille
,
Sébastien Taix
et al.
Journal articles
hal-02533424v1
|
|
Author Correction: Genomic characterization of metastatic breast cancers
Francois Bertucci
,
Charlotte Ng
,
Anne Patsouris
,
Nathalie Droin
,
Salvatore Piscuoglio
et al.
Journal articles
hal-02504834v1
|
|
PDL1 expression is associated with longer postoperative, survival in adrenocortical carcinoma
Emilien Billon
,
Pascal Finetti
,
Alexandre Bertucci
,
Patricia Niccoli
,
Daniel Birnbaum
et al.
Journal articles
hal-02509464v1
|
|
Sensitive and easy screening for circulating tumor cells by flow cytometry
Alexia Lopresti
,
Fabrice Malergue
,
François Bertucci
,
Maria Lucia Liberatoscioli
,
Séverine Garnier
et al.
Journal articles
hal-02529764v1
|
|
Programmed cell death 1 (PD-1) targeting in patients with advanced osteosarcomas: results from the PEMBROSARC study
A. Le Cesne
,
P. Marec-Berard
,
J.-Y. Blay
,
N. Gaspar
,
F. Bertucci
et al.
Journal articles
hal-02529696v1
|
|
Pathological grade-independent prediction of chemosensitivity by CINSARC should rehabilitate adjuvant chemotherapy in soft tissue sarcomas of any grade
F. Bertucci
,
P. Finetti
,
A. Monneur
,
D. Birnbaum
Journal articles
hal-02505000v1
|
|
PD-1/PD-L1 Targeting in Breast Cancer: The First Clinical Evidences Are Emerging. A Literature Review
Gabrielle Planes-Laine
,
Philippe Rochigneux
,
François Bertucci
,
Anne-Sophie Chrétien
,
Patrice Viens
et al.
Journal articles
hal-02533030v1
|
|
Genomic characterization of metastatic breast cancers
Francois Bertucci
,
Charlotte Ng
,
Anne Patsouris
,
Nathalie Droin
,
Salvatore Piscuoglio
et al.
Journal articles
hal-02504838v1
|
|
Successful Imatinib Treatment of an Abdominal Compartment Syndrome due to Huge Gastrointestinal Stromal Tumour
Alexandre Bertucci
,
Jérôme Guiramand
,
Lena Mescam
,
Audrey Monneur
,
Magali Bisbal
et al.
Journal articles
hal-02504820v1
|
|
ESR1 mutations in metastatic lobular breast cancer patients
Christine Desmedt
,
Julien Pingitore
,
Françoise Rothé
,
Caterina Marchio
,
Florian Clatot
et al.
Journal articles
hal-02352890v1
|
|
Overexpression of Annexin A1 Is an Independent Predictor of Longer Overall Survival in Epithelial Ovarian Cancer
Maroua Manai
,
Raoudha Doghri
,
Pascal Finetti
,
Karima Mrad
,
Rihab Bouabsa
et al.
Journal articles
hal-03623682v1
|
|
Pazopanib or methotrexate–vinblastine combination chemotherapy in adult patients with progressive desmoid tumours (DESMOPAZ): a non-comparative, randomised, open-label, multicentre, phase 2 study
Maud Toulmonde
,
Marina Pulido
,
Isabelle Ray-Coquard
,
Thierry André
,
Nicolas Isambert
et al.
Journal articles
hal-02533355v1
|
|
PDL1 expression is associated with longer postoperative, survival in adrenocortical carcinoma
Emilien Billon
,
Pascal Finetti
,
Alexandre Bertucci
,
Patricia Niccoli
,
Daniel Birnbaum
et al.
Journal articles
hal-03606482v1
|
|
Results of API–AI based regimen in osteosarcoma adult patients included in the French OS2006/Sarcome‐09 study
Sophie Piperno-Neumann
,
Isabelle Ray-Coquard
,
Bob-Valéry Occean
,
Valérie Laurence
,
Didier Cupissol
et al.
Journal articles
hal-02530602v1
|
|
Can we cure patients with abdominal Desmoplastic Small Round Cell Tumor? Results of a retrospective multicentric study on 100 patients
C. Honore
,
J.B. Delhorme
,
E. Nassif
,
M. Faron
,
G. Ferron
et al.
Journal articles
hal-02528457v1
|
|
PARP1 expression in soft tissue sarcomas is a poor‐prognosis factor and a new potential therapeutic target
Francois Bertucci
,
Pascal Finetti
,
Audrey Monneur
,
Delphine Perrot
,
Christine Chevreau
et al.
Journal articles
hal-02504850v1
|
|
Impact of Metastasis Surgery and Alkylating-Agent-Based Chemotherapy on Outcomes of Metastatic Malignant Phyllodes Tumors: A Multicenter Retrospective Study
Mathias Neron
,
Christophe Sajous
,
Simon Thezenas
,
Sophie Piperno-Neumann
,
Fabien Reyal
et al.
Journal articles
hal-02530556v1
|
|
Liquid Biopsies for Ovarian Carcinoma: How Blood Tests May Improve the Clinical Management of a Deadly Disease
Roxane Mari
,
Emilie Mamessier
,
Eric Lambaudie
,
Magali Provansal
,
Daniel Birnbaum
et al.
Journal articles
hal-02152656v1
|
|
Outpatient Cancer Care Delivery in the Context of E-Oncology: A French Perspective on “Cancer outside the Hospital Walls”
Francois Bertucci
,
Anne-Gaëlle Le Corroller-Soriano
,
Audrey Monneur-Miramon
,
Jean-François Moulin
,
Sylvain Fluzin
et al.
Journal articles
hal-02504845v1
|
|
Liquid Biopsies for Ovarian Carcinoma: How Blood Tests May Improve the Clinical Management of a Deadly Disease
Roxane Mari
,
Emilie Mamessier
,
Eric Lambaudie
,
Magali Provansal
,
Daniel Birnbaum
et al.
Journal articles
hal-03606425v1
|
|
ProNGF increases breast tumor aggressiveness through functional association of TrkA with EphA2
Romain Lévêque
,
Cyril Corbet
,
Léo Aubert
,
Matthieu Guilbert
,
Chann Lagadec
et al.
Journal articles
hal-02529705v1
|
|
A genome-wide RNAi screen reveals essential therapeutic targets of breast cancer stem cells
Abir Arfaoui
,
Claire Rioualen
,
Violette Azzoni
,
Guillaume Pinna
,
Pascal Finetti
et al.
Journal articles
hal-02539524v1
|
|
Localized high grade endometrial stromal sarcoma and localized undifferentiated uterine sarcoma: a retrospective series of the French Sarcoma Group
Marie Meurer
,
A. Floquet
,
I Ray-Coquard
,
F. Bertucci
,
M Auriche
et al.
Journal articles
hal-02530373v1
|
|
Determinants of favorable or unfavorable opinion about euthanasia in a sample of French cancer patients receiving palliative care
Alexandre de Nonneville
,
François Bertucci
,
Pascal Finetti
,
D. Perrot
,
M. Nilbert
et al.
Journal articles
hal-03583406v1
|
|
A major response to carboplatin in a metastatic triple-negative breast cancer patient with somatic mutation of BRCA1 and RAD51B: When chemotherapy meets precision medicine
L. Seguin
,
M. Chaffanet
,
R. Sabatier
,
A. Jose
,
S. Garnier
et al.
Journal articles
hal-02143656v1
|
|
Stromal Expression of MARCKS Protein in Ovarian Carcinomas Has Unfavorable Prognostic Value
Raoudha Doghri
,
Maroua Manai
,
Pascal Finetti
,
Maha Driss
,
Emilie Agavnian
et al.
Journal articles
hal-02143620v1
|
|
Development of parallel reaction monitoring (PRM)-based quantitative proteomics applied to HER2-Positive breast cancer
Mathilde Guérin
,
Anthony Gonçalves
,
Yves Toiron
,
Emilie Baudelet
,
Matthieu Pophillat
et al.
Journal articles
hal-02145636v1
|
|
Targeting BRCA Deficiency in Breast Cancer: What are the Clinical Evidences and the Next Perspectives?
Emanuel Nicolas
,
Francois Bertucci
,
Renaud Sabatier
,
Anthony Goncalves
Journal articles
hal-02143625v1
|
|
``Wnt/beta-Catenin in GIST''-Letter
Francois Bertucci
,
Pascal Finetti
,
Alexandre de Nonneville
,
Daniel Birnbaum
Journal articles
hal-02143618v1
|
|
The immunologic constant of rejection classification refines the prognostic value of conventional prognostic signatures in breast cancer
François Bertucci
,
Pascal Finetti
,
Ines Simeone
,
Wouter Hendrickx
,
Ena Wang
et al.
Journal articles
hal-03606514v1
|
|
PD-L1 expression and PD-1/PD-L1 inhibitors in breast cancer
Audrey Monneur
,
Anthony Goncalves
,
Francois Bertucci
Journal articles
hal-02143676v1
|
|
CMTM6 stabilizes PD-L1 expression and refines its prognostic value in tumors
Emilie Mamessier
,
David Birnbaum
,
Pascal Finetti
,
Daniel Birnbaum
,
François Bertucci
et al.
Journal articles
hal-01765411v1
|
|
Prognostic and predictive factors for angiosarcoma patients receiving paclitaxel once weekly plus or minus bevacizumab: an ancillary study derived from a randomized clinical trial
Loïc Lebellec
,
François Bertucci
,
Emmanuelle Tresch-Bruneel
,
Isabelle Ray-Coquard
,
Axel Le Cesne
et al.
Journal articles
inserm-02050851v1
|
|
Inflammatory breast cancer in 210�patients: A retrospective study on epidemiological, anatomo‑clinical features and therapeutic results
Maroua Manai
,
Pascal Finetti
,
Nesrine Mejri
,
Salma Athimni
,
Daniel Birnbaum
et al.
Journal articles
hal-02530356v1
|
|
Rates of immune cell infiltration in patients with triple-negative breast cancer by molecular subtype
Kenichi Harano
,
Ying Wang
,
Bora Lim
,
Robert S. Seitz
,
Stephan W. Morris
et al.
Journal articles
hal-02143557v1
|
|
Poly (ADP-Ribose) Polymerase Inhibitors for De Novo BRCA2-Null Small-Cell Prostate Cancer
Brice Chanez
,
Max Chaffanet
,
José Adélaide
,
Jeanne Thomassin
,
Séverine Garnier
et al.
Journal articles
hal-03623699v1
|
|
Targeting BRCA Deficiency in Breast Cancer: What are the Clinical Evidences and the Next Perspectives?
Emanuel Nicolas
,
François Bertucci
,
Renaud Sabatier
,
Anthony Gonçalves
Journal articles
hal-03669695v1
|
|
Molecular classification as prognostic factor and guide for treatment decision of pancreatic cancer
David Birnbaum
,
François Bertucci
,
Pascal Finetti
,
Daniel Birnbaum
,
Emilie Mamessier
et al.
Journal articles
hal-03583468v1
|
|
CDKN2A/B Deletion and Double-hit Mutations of the MAPK Pathway Underlie the Aggressive Behavior of Langerhans Cell Tumors
Luc Xerri
,
José Adelaïde
,
Cornel Popovici
,
Séverine Garnier
,
Arnaud Guille
et al.
Journal articles
hal-01788565v1
|
|
Safety Results and Analysis of Eribulin Efficacy according to Previous Microtubules-Inhibitors Sensitivity in the French Prospective Expanded Access Program for Heavily Pre-treated Metastatic Breast Cancer
Renaud Sabatier
,
Véronique Diéras
,
Xavier B. Pivot
,
Etienne Brain
,
Henri Roche
et al.
Journal articles
inserm-01985845v1
|
|
Ex vivo CSC assays for personalized testing of drug susceptibility in advanced breast cancer
Emmanuelle Charafe-Jauffret
,
Julien Wicinski
,
Olivier Cabaud
,
Marc Lopez
,
Stephane Audebert
et al.
Cancer Research, 2018, 78 (4, S)
Journal articles
hal-02143678v1
|
|
Reversible rituximab-induced rectal Kaposi's sarcoma misdiagnosed as ulcerative colitis in a patient with HIV-negative follicular lymphoma
Emilien Billon
,
Anne-Marie Stoppa
,
Lena Mescam
,
Massimo Bocci
,
Audrey Monneur
et al.
Journal articles
hal-02143666v1
|
|
EPIGIST: An observational real-life study on patients with metastatic gastrointestinal stromal tumors receiving imatinib
Olivier Bouché
,
Axel Le Cesne
,
Maria Rios
,
Loic Chaigneau
,
Antoine Italiano
et al.
Journal articles
hal-02005925v1
|
|
The SCRIB Paralog LANO/LRRC1 Regulates Breast Cancer Stem Cell Fate through WNT/beta-Catenin Signaling
Leonor Lopez Almeida
,
Michael Sebbagh
,
Francois Bertucci
,
Pascal Finetti
,
Julien Wicinski
et al.
Journal articles
hal-02143631v1
|
|
Impact of Trabectedin Interruption and Subsequent Rechallenge on Progression in Patients With Advanced Soft Tissue Sarcoma
Nuria Kotecki
,
Axel Le Cesne
,
Emmanuelle Tresch-Bruneel
,
Isabelle Ray-Coquard
,
Christine Chevreau
et al.
Journal articles
hal-03623697v1
|
|
The immunologic constant of rejection classification refines the prognostic value of conventional prognostic signatures in breast cancer
Francois Bertucci
,
Pascal Finetti
,
Ines Simeone
,
Wouter Hendrickx
,
Ena Wang
et al.
Journal articles
hal-02143596v1
|
|
Metastatic Intimal Sarcoma of the Pulmonary Artery Sensitive to Carboplatin-Vinorelbine Chemotherapy: Case Report and Literature Review
Marie Cantaloube
,
Laurence Moureau-Zabotto
,
Lena Mescam
,
Audrey Monneur
,
Valeria Deluca
et al.
Journal articles
hal-02143619v1
|
|
Giant Pedunculated Hepatic Hemangioma: A Case Report and Literature Review
Abdallah Al farai
,
Lénaïg Mescam
,
Valeria De luca
,
Audrey Monneur
,
Delphine Perrot
et al.
Journal articles
hal-03623704v1
|
|
The Genomic Grade Index predicts postoperative clinical outcome in patients with soft-tissue sarcoma
F Bertucci
,
A de Nonneville
,
P Finetti
,
D Perrot
,
M Nilbert
et al.
Journal articles
hal-01787485v1
|
|
Efficacy and safety of regorafenib compared to placebo and to post-cross-over regorafenib in advanced non-adipocytic soft tissue sarcoma
Christine Desmedt
,
Roberto Salgado
,
Marco Fornili
,
Giancarlo Pruneri
,
Gert van den Eynden
et al.
Journal articles
hal-03623702v1
|
|
Localized Myxofibrosarcomas: Roles of Surgical Margins and Adjuvant Radiation Therapy
Raoudha Boughzala-Bennadji
,
Eberhard Stoeckle
,
Cécile Le Péchoux
,
Pierre Méeus
,
Charles Honoré
et al.
Journal articles
hal-02049039v1
|
|
The use of systemic therapies to prevent progression of inflammatory breast cancer: which targeted therapies to add on cytotoxic combinations?
Anthony Gonçalves
,
Audrey Monneur
,
Patrice Viens
,
François Bertucci
Journal articles
hal-03623715v1
|
|
Circulating Tumour Cells and pathological complete response: independent prognostic factors in inflammatory breast cancer in a pooled analysis of two multicentre phase II trials (BEVERLY-1 and -2) of neoadjuvant chemotherapy combined with bevacizumab
J-y Pierga
,
F-C Bidard
,
A. Autret
,
T. Petit
,
F. André
et al.
Journal articles
inserm-01985299v1
|
|
A 25-gene classifier predicts overall survival in resectable pancreatic cancer
David Birnbaum
,
Pascal Finetti
,
Alexia Lopresti
,
Marine Gilabert
,
Flora Poizat
et al.
Journal articles
hal-01787872v1
|
|
Wnt Signaling Inhibition Promotes Apoptosis in Sarcomas—Letter
François Bertucci
,
Pascal Finetti
,
Daniel Birnbaum
Journal articles
hal-01787271v1
|
|
Prediction of local and metastatic recurrence in solitary fibrous tumor: construction of a risk calculator in a multicenter cohort from the French Sarcoma Group (FSG) database
S. Salas
,
N. Resseguier
,
J. Y. Blay
,
A. Le Cesne
,
A. Italiano
et al.
Journal articles
hal-01655970v1
|
|
miR-600 Acts as a Bimodal Switch that Regulates Breast Cancer Stem Cell Fate through WNT Signaling
Rita El Helou
,
Guillaume Pinna
,
Olivier Cabaud
,
Julien Wicinski
,
Ricky Bhajun
et al.
Journal articles
hal-01789620v1
|
|
Gastrointestinal Stromal Tumour with Synchronous Bone Metastases: A Case Report and Literature Review
Philippe Rochigneux
,
Lénaig Mescam-Mancini
,
Delphine Perrot
,
Erwan Bories
,
Laurence Moureau-Zabotto
et al.
Journal articles
hal-03623722v1
|
|
Prognostic Value of Molecular Subtypes in Pancreatic Cancer
François Bertucci
,
David Birnbaum
,
Pascal Finetti
,
Marine Gilabert
,
Flora Poizat
et al.
Journal articles
hal-03606452v1
|
|
Nectine-4 : un biomarqueur pronostique et une cible thérapeutique potentielle dans le cancer du sein triple-négatif
Manel M 'Rabet
,
François Bertucci
,
Daniel Birnbaum
,
Marc Lopez
médecine/sciences, 2017
Journal articles
hal-01788721v1
|
|
Immunotherapy in Breast Cancer: the Emerging Role of PD-1 and PD-L1
François Bertucci
,
Anthony Gonçalves
Journal articles
hal-03623712v1
|
|
PDL1 expression is a poor-prognosis factor in soft-tissue sarcomas
François Bertucci
,
Pascal Finetti
,
Delphine Perrot
,
Agnès Leroux
,
Françoise Collin
et al.
Journal articles
hal-01765418v1
|
|
A scoring system to guide the decision for a new systemic treatment after at least two lines of palliative chemotherapy for metastatic cancers: a prospective study
Brice Chanez
,
François Bertucci
,
Marine Gilabert
,
Anne Madroszyk
,
Frédérique Rousseau
et al.
Journal articles
hal-03623718v1
|
|
Characterization and Targeting of Platelet-Derived Growth Factor Receptor alpha (PDGFRA) in Inflammatory Breast Cancer (IBC)
Madhura Joglekar-Javadekar
,
Steven van Laere
,
Michael Bourne
,
Manal Moalwi
,
Pascal Finetti
et al.
Journal articles
hal-01789694v1
|
|
A retrospective multicentric study of ewing sarcoma family of tumors in patients older than 50: management and outcome
Pauline Rochefort
,
Antoine Italiano
,
Valérie Laurence
,
Nicolas Penel
,
Audrey Lardy-Cleaud
et al.
Journal articles
hal-02613645v1
|
|
Regosarc: regorafenib versus placebo in doxorubicin-refractory soft-tissue sarcoma-a quality-adjusted time without symptoms of progression or toxicity analysis
Vincent Berry
,
Laurent Basson
,
Emilie Bogart
,
Olivier Mir
,
Jean-Yves Blay
et al.
Journal articles
hal-02638646v1
|
|
miR-424(322)/503 is a breast cancer tumor suppressor whose loss promotes resistance to chemotherapy
Ruth Rodriguez-Barrueco
,
Erin A Nekritz
,
François Bertucci
,
Jiyang Yu
,
Felix Sanchez-Garcia
et al.
Journal articles
hal-01787959v1
|
|
A stemness-related ZEB1–MSRB3 axis governs cellular pliancy and breast cancer genome stability
Anne Morel
,
Christophe Ginestier
,
Roxane Pommier
,
Olivier Cabaud
,
Emmanuelle Ruiz
et al.
Journal articles
hal-01788395v1
|
|
Similar response profile to neoadjuvant chemotherapy, but different survival, in inflammatory versus locally advanced breast cancers
Audrey Monneur
,
Anthony Gonçalves
,
Marine Gilabert
,
Pascal Finetti
,
Carole Tarpin
et al.
Journal articles
inserm-01984755v1
|
|
Scientific summary from the Morgan Welch MD Anderson Cancer Center Inflammatory Breast Cancer (IBC) program 10th Anniversary Conference
Wendy Woodward
,
Massimo Cristofanilli
,
Sofia Merajver
,
Steven van Laere
,
Lajos Pusztai
et al.
Journal articles
hal-03623708v1
|
|
Benefit of adjuvant chemotherapy with or without trastuzumab in pT1ab node-negative human epidermal growth factor receptor 2-positive breast carcinomas: results of a national multi-institutional study
Alexandre de Nonneville
,
Anthony Gonçalves
,
Christophe Zemmour
,
Jean Classe
,
Monique Cohen
et al.
Journal articles
hal-03623719v1
|
|
Advanced chordoma treated by first-line molecular targeted therapies: Outcomes and prognostic factors. A retrospective study of the French Sarcoma Group (GSF/GETO) and the Association des Neuro-Oncologues d'Expression Française (ANOCEF)
Loïc Lebellec
,
Bruno Chauffert
,
Jean-Yves Blay
,
Axel Le Cesne
,
Christine Chevreau
et al.
Journal articles
hal-01655981v1
|
|
PIKHER2: A phase IB study evaluating buparlisib in combination with lapatinib in trastuzumab-resistant HER2-positive advanced breast cancer
Mathilde Guerin
,
Keyvan Rezai
,
Nicolas Isambert
,
Mario Campone
,
Aurélie Autret
et al.
Journal articles
hal-03623711v1
|
|
Erratum to: HDAC6 activity is a non-oncogene addiction hub for inflammatory breast cancers
Preeti Putcha
,
Jiyang Yu
,
Ruth Rodriguez-Barrueco
,
Laura Saucedo-Cuevas
,
Patricia Villagrasa
et al.
Journal articles
hal-03623716v1
|
|
Validation and comparison of the molecular classifications of pancreatic carcinomas
David Birnbaum
,
Pascal Finetti
,
Daniel Birnbaum
,
Emilie Mamessier
,
François Bertucci
et al.
Journal articles
hal-03583469v1
|
|
MARCKS protein overexpression in inflammatory breast cancer
Maroua Manai
,
Jeanne Thomassin-Piana
,
Amor Gamoudi
,
Pascal Finetti
,
Marc Lopez
et al.
Journal articles
hal-01787705v1
|
|
Identification of genetic determinants of breast cancer immune phenotypes by integrative genome-scale analysis
Wouter Hendrickx
,
Ines Simeone
,
Samreen Anjum
,
Younes Mokrab
,
François Bertucci
et al.
Journal articles
hal-01788951v1
|
|
An ICGC major achievement in breast cancer: a comprehensive catalog of mutations and mutational signatures
François Bertucci
,
Max Chaffanet
,
Daniel Birnbaum
Journal articles
hal-01787356v1
|
|
[Impact of Her2 and BRCA1/2 status in high-dose chemotherapy and autologous stem cells transplantation in the treatment of breast cancer: The Institut Paoli Calmettes' experience].
Laurys Boudin
,
Christian Chabannon
,
Patrick Sfumato
,
Renaud Sabatier
,
François Bertucci
et al.
Journal articles
hal-01788977v1
|
|
Surgical versus non-surgical approach in primary desmoid-type fibromatosis patients: A nationwide prospective cohort from the French Sarcoma Group
Nicolas Penel
,
Axel Le Cesne
,
Sylvie Bonvalot
,
Antoine Giraud
,
Emmanuelle Bompas
et al.
Journal articles
hal-03623713v1
|
|
Adjuvant chemotherapy in pT1ab node-negative triple-negative breast carcinomas: Results of a national multi-institutional retrospective study
A. de Nonneville
,
A. Goncalves
,
C. Zemmour
,
M. Cohen
,
J.M. Classe
et al.
Journal articles
hal-02282824v1
|
|
Nectin-4: a new prognostic biomarker for efficient therapeutic targeting of primary and metastatic triple-negative breast cancer
M. M-Rabet
,
O. Cabaud
,
E. Josselin
,
P. Finetti
,
R. Castellano
et al.
Journal articles
hal-01787533v1
|
|
Corrigendum to “Immunohistochemical subtypes predict survival in metastatic breast cancer receiving high-dose chemotherapy with autologous haematopoietic stem cell transplantation” [Eur J Cancer 57 (April 2016) 118–126]
Laurys Boudin
,
Christian Chabannon
,
Patrick Sfumato
,
Renaud Sabatier
,
François Bertucci
et al.
Journal articles
hal-03623727v1
|
|
Bevacizumab plus neoadjuvant chemotherapy in patients with HER2-negative inflammatory breast cancer (BEVERLY-1): a multicentre, single-arm, phase 2 study
François Bertucci
,
Mahmoud Fekih
,
Aurélie Autret
,
Thierry Petit
,
Florence Dalenc
et al.
Journal articles
hal-03623735v1
|
|
Prognostic impact of hormone receptor- and HER2-defined subtypes in inflammatory breast cancer treated with high-dose chemotherapy: a retrospective study
Laurys Boudin
,
Anthony Gonçalves
,
Patrick Sfumato
,
Renaud Sabatier
,
François Bertucci
et al.
Journal articles
inserm-01987531v1
|
|
PLZF mutation alters mouse hematopoietic stem cell function and cell cycle progression
Christelle Vincent-Fabert
,
Nadine Platet
,
Amelle Vandevelde
,
Mathilde Poplineau
,
Myriam Koubi
et al.
Journal articles
hal-03623736v1
|
|
Comparative genomic analysis of primary tumors and metastases in breast cancer
François Bertucci
,
Pascal Finetti
,
Arnaud Guille
,
José Adélaïde
,
Séverine Garnier
et al.
Journal articles
hal-03623731v1
|
|
Identification of p62/SQSTM1 as a component of non-canonical Wnt VANGL2–JNK signalling in breast cancer
Tania M. Puvirajesinghe
,
François Bertucci
,
Ashish Jain
,
Pierluigi Scerbo
,
Edwige Belotti
et al.
Journal articles
hal-01447570v1
|
|
SPAG5: the ultimate marker of proliferation in early breast cancer?
François Bertucci
,
Patrice Viens
,
Daniel Birnbaum
Journal articles
hal-03623730v1
|
|
Pregnane X-receptor promotes stem cell-mediated colon cancer relapse
Chris Planque
,
Fatemeh Rajabi
,
Fanny Grillet
,
Pascal Finetti
,
François Bertucci
et al.
Journal articles
hal-01431926v1
|
|
Prognostic value of PDL1 expression in pancreatic cancer
David Birnbaum
,
Pascal Finetti
,
Alexia Lopresti
,
Marine Gilabert
,
Flora Poizat
et al.
Journal articles
hal-01765421v1
|
|
PRICKLE1 contributes to cancer cell dissemination through its interaction with mTORC2
Avais M Daulat
,
François Bertucci
,
Stéphane Audebert
,
Arnauld Sergé
,
Pascal Finetti
et al.
Journal articles
hal-01321061v1
|
|
Safety and efficacy of regorafenib in patients with advanced soft tissue sarcoma (REGOSARC): a randomised, double-blind, placebo-controlled, phase 2 trial
Olivier Mir
,
Thomas Brodowicz
,
Antoine Italiano
,
Jennifer Wallet
,
Jean-Yves Blay
et al.
Journal articles
hal-03623726v1
|
|
Circulating vascular endothelial growth factor (VEGF) as predictive factor of progression-free survival in patients with advanced chordoma receiving sorafenib: an analysis from a phase II trial of the french sarcoma group (GSF/GETO)
Loic Lebellec
,
François Bertucci
,
Emmanuelle Tresch-Bruneel
,
Emmanuelle Bompas
,
Yves Toiron
et al.
Journal articles
hal-01453300v1
|
|
Prognostic value of PDL1 expression in pancreatic cancer
David Birnbaum
,
Pascal Finetti
,
Alexia Lopresti
,
Marine Gilabert
,
Flora Poizat
et al.
Journal articles
hal-03583475v1
|
|
Long-term outcome of molecular subgroups of GIST patients treated with standard-dose imatinib in the BFR14 trial of the French Sarcoma Group
A. Patrikidou
,
J. Domont
,
Sylvie Chabaud
,
Isabelle Ray-Coquard
,
J.M. Coindre
et al.
Journal articles
hal-01812685v1
|
|
Targeted NGS, array-CGH, and patient-derived tumor xenografts for precision medicine in advanced breast cancer: a single-center prospective study
Anthony Gonçalves
,
François Bertucci
,
Arnaud Guille
,
Severine Garnier
,
José Adelaide
et al.
Journal articles
hal-03623724v1
|
|
XPO1, therapeutic...and prognostic target in sarcomas
François Bertucci
,
Pascal Finetti
,
Daniel Birnbaum
Journal articles
hal-03623732v1
|
|
Genomic Characterization of Primary Invasive Lobular Breast Cancer
Christine Desmedt
,
Gabriele Zoppoli
,
Gunes Gundem
,
Giancarlo Pruneri
,
Denis Larsimont
et al.
Journal articles
hal-03623737v1
|
|
Molecular targeted therapies (MTT) in advanced chordoma (AC) patients (pts).
Loic Lebellec
,
Axel Le Cesne
,
Nicolas Penel
,
Jean -Yves Blay
,
Christine Chevreau
et al.
Journal articles
hal-03598684v1
|
|
Expression of Genes with Copy Number Alterations and Survival of Patients with Pancreatic Adenocarcinoma.
David Birnbaum
,
François Bertucci
,
Pascal Finetti
,
José Adélaïde
,
Marc Giovannini
et al.
Cancer Genomics and Proteomics, 2016, 13 (3), pp.191-200
Journal articles
hal-03583479v1
|
|
Bevacizumab in HER2-negative inflammatory breast cancer
François Bertucci
,
Anthony Goncalves
,
Patrice Viens
Journal articles
hal-03623723v1
|
|
Pazopanib plus best supportive care versus best supportive care alone in advanced gastrointestinal stromal tumours resistant to imatinib and sunitinib (PAZOGIST): a randomised, multicentre, open-label phase 2 trial
Olivier Mir
,
Claire Cropet
,
Maud Toulmonde
,
Axel Le Cesne
,
Mathieu Molimard
et al.
Journal articles
hal-03623734v1
|
|
Management of desmoid tumours: A nationwide survey of labelled reference centre networks in France
N. Penel
,
J.M. Coindre
,
S. Bonvalot
,
A. Italiano
,
A. Neuville
et al.
Journal articles
hal-01812682v1
|
|
MMP2 and MMP9 serum levels are associated with favorable outcome in patients with inflammatory breast cancer treated with bevacizumab-based neoadjuvant chemotherapy in the BEVERLY-2 study
Emeline Tabouret
,
François Bertucci
,
Jean-Yves Pierga
,
Thierry Petit
,
Christelle Levy
et al.
Journal articles
hal-03623733v1
|
|
Autocrine Secretion of Progastrin Promotes the Survival and Self-Renewal of Colon Cancer Stem-like Cells
Julie Giraud
,
Laura Failla
,
Jean-Marc Pascussi
,
Ebba Louise Lagerqvist
,
Jérémy Ollier
et al.
Journal articles
hal-01905320v1
|
|
Guideline sheets on the side effects of anticancer drugs are useful for general practitioners
Marie-Eve Rouge-Bugat
,
Donia Lassoued
,
Joy Bacrie
,
Nathalie Boussier
,
Jean-Pierre Delord
et al.
Journal articles
hal-01914751v1
|
|
HDAC6 activity is a non-oncogene addiction hub for inflammatory breast cancers
Preeti Putcha
,
Jiyang Yu
,
Ruth Rodriguez-Barrueco
,
Laura Saucedo-Cuevas
,
Patricia Villagrasa
et al.
Journal articles
inserm-01254136v1
|
|
NGF-induced TrkA/CD44 association is involved in tumor aggressiveness and resistance to lestaurtinib
Léo Aubert
,
Matthieu Guilbert
,
Cyril Corbet
,
Elisabeth Génot
,
Eric Adriaenssens
et al.
Journal articles
hal-03623750v1
|
|
High-grade soft tissue sarcoma arising in a desmoid tumor: case report and review of the literature
François Bertucci
,
Marjorie Faure
,
Maria-Rosa Ghigna
,
Bruno Chetaille
,
Jérôme Guiramand
et al.
Journal articles
hal-03623738v1
|
|
Decreased expression of ABAT and STC2 hallmarks ER-positive inflammatory breast cancer and endocrine therapy resistance in advanced disease
Maurice P.H.M. Jansen
,
Leen Sas
,
Anieta Sieuwerts
,
Caroline van Cauwenberghe
,
Diana Ramirez-Ardila
et al.
Journal articles
hal-03623744v1
|
|
Prediction of Early Breast Cancer Metastasis from DNA Microarray Data Using High-Dimensional Cox Regression Models
Christophe Zemmour
,
Francois Bertucci
,
Pascal Finetti
,
Bernard Chetrit
,
Daniel Birnbaum
et al.
Journal articles
inserm-01996812v1
|
|
The E2F4 prognostic signature is also predictive of the pathological response of breast cancer to chemotherapy
François Bertucci
,
Pascal Finetti
,
Daniel Birnbaum
Journal articles
hal-03623743v1
|
|
The PD1/PDL1 axis, a promising therapeutic target in aggressive breast cancers
François Bertucci
,
Pascal Finetti
,
Daniel Birnbaum
,
Emilie Mamessier
Journal articles
hal-03583477v1
|
|
PDL1 expression is an independent prognostic factor in localized GIST
François Bertucci
,
Pascal Finetti
,
Emilie Mamessier
,
Maria Abbondanza Pantaleo
,
Annalisa Astolfi
et al.
Journal articles
hal-03583480v1
|
|
Simvastatin prevents triple-negative breast cancer metastasis in pre-clinical models through regulation of FOXO3a
Adam Wolfe
,
Bisrat Debeb
,
Lara Lacerda
,
Richard Larson
,
Arvind Bambhroliya
et al.
Journal articles
hal-03623740v1
|
|
Trabectedin in combination with doxorubicin for first-line treatment of advanced uterine or soft-tissue leiomyosarcoma (LMS-02): a non-randomised, multicentre, phase 2 trial
Patricia Pautier
,
Anne Floquet
,
Christine Chevreau
,
Nicolas Penel
,
Cécile Guillemet
et al.
Journal articles
hal-03623745v1
|
|
Trabectedin in patients with advanced soft tissue sarcoma: A retrospective national analysis of the French Sarcoma Group
Axel Le Cesne
,
Isabelle Ray-Coquard
,
Florence Duffaud
,
Christine Chevreau
,
Nicolas Penel
et al.
Journal articles
hal-03623749v1
|
|
Systems biology analysis reveals NFAT5 as a novel biomarker and master regulator of inflammatory breast cancer
Andrea Remo
,
Ines Simeone
,
Massimo Pancione
,
Pietro Parcesepe
,
Pascal Finetti
et al.
Journal articles
inserm-01264508v1
|
|
BRCA1 haplotype and clinical benefit of trabectedin in soft-tissue sarcoma patients
A Laroche-Clary
,
V Chaire
,
V Le Morvan
,
A. Neuville
,
F. Bertucci
et al.
Journal articles
hal-02277467v1
|
|
PDL1 expression in inflammatory breast cancer is frequent and predicts for the pathological response to chemotherapy
|